Am. J. Respir. Crit. Care Med., Volume 162, Number 2, August 2000, 393-398

Improvements in Outcomes of Acute Respiratory Failure for Patients with Human Immunodeficiency Virus-related Pneumocystis carinii Pneumonia

J. RANDALL CURTIS, PAUL R. YARNOLD, DAVID N. SCHWARTZ, ROBERT A. WEINSTEIN, and CHARLES L. BENNETT

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington; Division of General Medicine, Northwestern University Medical School, Evanston, Illinois; Cook County Hospital, Rush Medical College, Chicago, Illinois; and Chicago VA Healthcare System/Lakeside Division and the Department of Medicine, the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois

In the early 1990s, hospital survival among patients with human immunodeficiency virus (HIV)-related Pneumocystis carinii pneumonia (PCP) and respiratory failure was poor, approximately 20%. We examined ICU use and outcomes for patients with acute respiratory failure from PCP from 1995 to 1997. We conducted a retrospective medical record review using a random sample of 71 hospitals in seven regions of the United States. Among 1,660 patients with confirmed or presumed PCP, 155 (9%) received mechanical ventilation for respiratory failure. Factors that predicted use of mechanical ventilation, independent of severity of illness on hospital admission, included African-American ethnicity and geographic location (p  0.002). Hospital survival for patients receiving mechanical ventilation was 38% (95% CI 30, 46). Controlling for severity of illness, patients who were on PCP prophylaxis prior to developing PCP were less likely to survive to hospital discharge (p  0.02). There were no significant differences in hospital survival regardless of whether patients had received less than or more than 5 d of PCP treatment prior to respiratory failure (39 versus 29%; p = 0.5). In conclusion, from 1995 to 1997, hospital survival after PCP requiring mechanical ventilation was approximately 40%. Physicians caring for patients with severe HIV-related PCP should be aware of the improvements in outcomes for this disease before making recommendations about withholding or withdrawing ventilatory support for respiratory failure.

This article has been cited by other articles:

				M W Fei, E J Kim, C A Sant, L G Jarlsberg, J L Davis, A Swartzman, and L Huang Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study Thorax, December 1, 2009; 64(12): 1070 - 1076. [Abstract] [Full Text] [PDF]

				G. S. Pryhuber, H. L. Huyck, S. Bhagwat, M. A. O'Reilly, J. N. Finkelstein, F. Gigliotti, and T. W. Wright Parenchymal Cell TNF Receptors Contribute to Inflammatory Cell Recruitment and Respiratory Failure in Pneumocystis carinii-Induced Pneumonia J. Immunol., July 15, 2008; 181(2): 1409 - 1419. [Abstract] [Full Text] [PDF]

				R. E. Davaro and A. Thirumalai Life-Threatening Complications of HIV Infection J Intensive Care Med, March 1, 2007; 22(2): 73 - 81. [Abstract] [PDF]

				R F Miller, E Allen, A Copas, M Singer, and S G Edwards Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy Thorax, August 1, 2006; 61(8): 716 - 721. [Abstract] [Full Text] [PDF]

				H. Khouli, A. Afrasiabi, M. Shibli, R. Hajal, C. R. Barrett, and P. Homel Outcome of Critically Ill Human Immunodeficiency Virus-Infected Patients in the Era of Highly Active Antiretroviral Therapy J Intensive Care Med, December 1, 2005; 20(6): 279 - 285. [Abstract] [PDF]

				M. J. Rosen Intensive Care of Patients With Human Immunodeficiency Virus Infection: Time to Take Another Look J Intensive Care Med, December 1, 2005; 20(6): 312 - 315. [PDF]

				S. E. Evans, P. Y. Hahn, F. McCann, T. J. Kottom, Z. V. Pavlovic', and A. H. Limper Pneumocystis Cell Wall {beta}-Glucans Stimulate Alveolar Epithelial Cell Chemokine Generation through Nuclear Factor-{kappa}B-Dependent Mechanisms Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 490 - 497. [Abstract] [Full Text] [PDF]

				C. F. Thomas Jr. and A. H. Limper Pneumocystis Pneumonia N. Engl. J. Med., June 10, 2004; 350(24): 2487 - 2498. [Full Text] [PDF]

				R J Boyton, D M Mitchell, and O M Kon The pulmonary physician in critical care * Illustrative case 5: HIV associated pneumonia Thorax, August 1, 2003; 58(8): 721 - 725. [Full Text] [PDF]

				A. Morris, J. Creasman, J. Turner, J. M. Luce, R. M. Wachter, and L. Huang Intensive Care of Human Immunodeficiency Virus-infected Patients during the Era of Highly Active Antiretroviral Therapy Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 262 - 267. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF]

				H. Ahmad, N. J. Mehta, V. M. Manikal, T. J. Lamoste, E. K. Chapnick, L. I. Lutwick, and D. V. Sepkowitz Pneumocystis carinii Pneumonia in Pregnancy Chest, August 1, 2001; 120(2): 666 - 671. [Abstract] [Full Text] [PDF]

				N. S. Hill Noninvasive Ventilation for Immunocompromised Patients N. Engl. J. Med., February 15, 2001; 344(7): 522 - 524. [Full Text] [PDF]

				L. J. Schneiderman, N. S. Jecker, A. R. Jonsen, J. R. Curtis, D. L. Patrick, E. S. Caldwell, and A. C. Collier Abuse of Futility Arch Intern Med, January 8, 2001; 161(1): 128 - 130. [Full Text] [PDF]